HEADER HYDROLASE/HYDROLASE INHIBITOR 07-NOV-17 5YQO TITLE CRYSTAL STRUCTURE OF SIRT2 IN COMPLEX WITH SELECTIVE INHIBITOR L5C COMPND MOL_ID: 1; COMPND 2 MOLECULE: NAD-DEPENDENT PROTEIN DEACETYLASE SIRTUIN-2; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: REGULATORY PROTEIN SIR2 HOMOLOG 2,SIR2-LIKE PROTEIN 2; COMPND 5 EC: 3.5.1.-; COMPND 6 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: SIRT2, SIR2L, SIR2L2; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS NAD-DEPENDENT DEACETYLASE SIRTUIN-2, INHIBITOR, COMPLEX, HYDROLASE- KEYWDS 2 HYDROLASE INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR H.WANG,Y.YU,G.LI,Q.CHEN REVDAT 2 22-NOV-23 5YQO 1 REMARK REVDAT 1 17-OCT-18 5YQO 0 JRNL AUTH L.L.YANG,H.L.WANG,L.ZHONG,C.YUAN,S.Y.LIU,Z.J.YU,S.LIU, JRNL AUTH 2 Y.H.YAN,C.WU,Y.WANG,Z.WANG,Y.YU,Q.CHEN,G.B.LI JRNL TITL X-RAY CRYSTAL STRUCTURE GUIDED DISCOVERY OF NEW SELECTIVE, JRNL TITL 2 SUBSTRATE-MIMICKING SIRTUIN 2 INHIBITORS THAT EXHIBIT JRNL TITL 3 ACTIVITIES AGAINST NON-SMALL CELL LUNG CANCER CELLS. JRNL REF EUR J MED CHEM V. 155 806 2018 JRNL REFN ISSN 1768-3254 JRNL PMID 29957526 JRNL DOI 10.1016/J.EJMECH.2018.06.041 REMARK 2 REMARK 2 RESOLUTION. 1.48 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX 1.8.4_1496 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.48 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 44.33 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.360 REMARK 3 COMPLETENESS FOR RANGE (%) : 96.0 REMARK 3 NUMBER OF REFLECTIONS : 46070 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.170 REMARK 3 R VALUE (WORKING SET) : 0.169 REMARK 3 FREE R VALUE : 0.193 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.820 REMARK 3 FREE R VALUE TEST SET COUNT : 2222 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 44.3520 - 3.7358 0.98 2845 144 0.1623 0.1627 REMARK 3 2 3.7358 - 2.9654 0.99 2835 155 0.1568 0.1720 REMARK 3 3 2.9654 - 2.5906 0.99 2853 137 0.1595 0.1867 REMARK 3 4 2.5906 - 2.3538 0.99 2818 147 0.1578 0.1997 REMARK 3 5 2.3538 - 2.1851 0.98 2837 128 0.1584 0.1806 REMARK 3 6 2.1851 - 2.0562 0.99 2798 147 0.1627 0.1779 REMARK 3 7 2.0562 - 1.9533 0.99 2851 161 0.1652 0.2088 REMARK 3 8 1.9533 - 1.8682 0.99 2764 152 0.1723 0.2121 REMARK 3 9 1.8682 - 1.7963 0.98 2802 133 0.1768 0.2210 REMARK 3 10 1.7963 - 1.7343 0.99 2856 137 0.1801 0.2058 REMARK 3 11 1.7343 - 1.6801 0.98 2764 153 0.1924 0.2048 REMARK 3 12 1.6801 - 1.6321 0.98 2781 145 0.1886 0.2243 REMARK 3 13 1.6321 - 1.5891 0.97 2772 140 0.1916 0.2414 REMARK 3 14 1.5891 - 1.5503 0.93 2640 133 0.2140 0.2289 REMARK 3 15 1.5503 - 1.5151 0.87 2492 126 0.2222 0.2919 REMARK 3 16 1.5151 - 1.4828 0.75 2140 84 0.2613 0.2800 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : NULL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.150 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 20.550 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.006 2393 REMARK 3 ANGLE : 1.079 3232 REMARK 3 CHIRALITY : 0.060 346 REMARK 3 PLANARITY : 0.004 416 REMARK 3 DIHEDRAL : 14.482 893 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 5YQO COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 15-NOV-17. REMARK 100 THE DEPOSITION ID IS D_1300005737. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 29-JUN-17 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SSRF REMARK 200 BEAMLINE : BL19U1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.979 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-3000 REMARK 200 DATA SCALING SOFTWARE : HKL-3000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 47551 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.483 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.5 REMARK 200 DATA REDUNDANCY : 5.900 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 8.9000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.48 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : NULL REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: 5MAT REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 42.42 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.14 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 2.1M DL-MALIC ACID PH7.0, VAPOR REMARK 280 DIFFUSION, HANGING DROP, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 36.95900 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 0 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 14050 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: 0.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 102 REMARK 465 LEU A 103 REMARK 465 TYR A 104 REMARK 465 ASP A 105 REMARK 465 ASN A 106 REMARK 465 LEU A 107 REMARK 465 GLU A 108 REMARK 465 LYS A 109 REMARK 465 TYR A 110 REMARK 465 HIS A 111 REMARK 465 LEU A 112 REMARK 465 GLY A 298 REMARK 465 MET A 299 REMARK 465 ILE A 300 REMARK 465 MET A 301 REMARK 465 GLY A 302 REMARK 465 LEU A 303 REMARK 465 GLY A 304 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 O HOH A 568 O HOH A 762 2.11 REMARK 500 O HOH A 506 O HOH A 761 2.12 REMARK 500 O HOH A 712 O HOH A 798 2.13 REMARK 500 OE1 GLU A 181 O HOH A 501 2.15 REMARK 500 O HOH A 821 O HOH A 835 2.15 REMARK 500 O HOH A 848 O HOH A 853 2.16 REMARK 500 O HOH A 649 O HOH A 778 2.18 REMARK 500 O HOH A 810 O HOH A 846 2.18 REMARK 500 O HOH A 747 O HOH A 790 2.18 REMARK 500 O HOH A 537 O HOH A 592 2.19 REMARK 500 O HOH A 696 O HOH A 809 2.19 REMARK 500 O HOH A 836 O HOH A 850 2.19 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ALA A 52 -147.19 -93.48 REMARK 500 CYS A 200 -70.76 -118.59 REMARK 500 ASP A 231 34.20 -73.55 REMARK 500 TYR A 315 -13.09 -145.42 REMARK 500 ARG A 316 -8.08 -151.10 REMARK 500 REMARK 500 REMARK: NULL REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH A 851 DISTANCE = 6.15 ANGSTROMS REMARK 525 HOH A 852 DISTANCE = 7.22 ANGSTROMS REMARK 525 HOH A 853 DISTANCE = 7.29 ANGSTROMS REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 ZN A 401 ZN REMARK 620 N RES CSSEQI ATOM REMARK 620 1 CYS A 195 SG REMARK 620 2 CYS A 200 SG 112.3 REMARK 620 3 CYS A 221 SG 109.7 107.7 REMARK 620 4 CYS A 224 SG 93.4 120.3 112.6 REMARK 620 N 1 2 3 REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue ZN A 401 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue L5C A 402 DBREF 5YQO A 56 356 UNP Q8IXJ6 SIR2_HUMAN 56 356 SEQADV 5YQO GLY A 51 UNP Q8IXJ6 EXPRESSION TAG SEQADV 5YQO ALA A 52 UNP Q8IXJ6 EXPRESSION TAG SEQADV 5YQO SER A 53 UNP Q8IXJ6 EXPRESSION TAG SEQADV 5YQO GLY A 54 UNP Q8IXJ6 EXPRESSION TAG SEQADV 5YQO SER A 55 UNP Q8IXJ6 EXPRESSION TAG SEQRES 1 A 306 GLY ALA SER GLY SER GLU ARG LEU LEU ASP GLU LEU THR SEQRES 2 A 306 LEU GLU GLY VAL ALA ARG TYR MET GLN SER GLU ARG CYS SEQRES 3 A 306 ARG ARG VAL ILE CYS LEU VAL GLY ALA GLY ILE SER THR SEQRES 4 A 306 SER ALA GLY ILE PRO ASP PHE ARG SER PRO SER THR GLY SEQRES 5 A 306 LEU TYR ASP ASN LEU GLU LYS TYR HIS LEU PRO TYR PRO SEQRES 6 A 306 GLU ALA ILE PHE GLU ILE SER TYR PHE LYS LYS HIS PRO SEQRES 7 A 306 GLU PRO PHE PHE ALA LEU ALA LYS GLU LEU TYR PRO GLY SEQRES 8 A 306 GLN PHE LYS PRO THR ILE CYS HIS TYR PHE MET ARG LEU SEQRES 9 A 306 LEU LYS ASP LYS GLY LEU LEU LEU ARG CYS TYR THR GLN SEQRES 10 A 306 ASN ILE ASP THR LEU GLU ARG ILE ALA GLY LEU GLU GLN SEQRES 11 A 306 GLU ASP LEU VAL GLU ALA HIS GLY THR PHE TYR THR SER SEQRES 12 A 306 HIS CYS VAL SER ALA SER CYS ARG HIS GLU TYR PRO LEU SEQRES 13 A 306 SER TRP MET LYS GLU LYS ILE PHE SER GLU VAL THR PRO SEQRES 14 A 306 LYS CYS GLU ASP CYS GLN SER LEU VAL LYS PRO ASP ILE SEQRES 15 A 306 VAL PHE PHE GLY GLU SER LEU PRO ALA ARG PHE PHE SER SEQRES 16 A 306 CYS MET GLN SER ASP PHE LEU LYS VAL ASP LEU LEU LEU SEQRES 17 A 306 VAL MET GLY THR SER LEU GLN VAL GLN PRO PHE ALA SER SEQRES 18 A 306 LEU ILE SER LYS ALA PRO LEU SER THR PRO ARG LEU LEU SEQRES 19 A 306 ILE ASN LYS GLU LYS ALA GLY GLN SER ASP PRO PHE LEU SEQRES 20 A 306 GLY MET ILE MET GLY LEU GLY GLY GLY MET ASP PHE ASP SEQRES 21 A 306 SER LYS LYS ALA TYR ARG ASP VAL ALA TRP LEU GLY GLU SEQRES 22 A 306 CYS ASP GLN GLY CYS LEU ALA LEU ALA GLU LEU LEU GLY SEQRES 23 A 306 TRP LYS LYS GLU LEU GLU ASP LEU VAL ARG ARG GLU HIS SEQRES 24 A 306 ALA SER ILE ASP ALA GLN SER HET ZN A 401 1 HET L5C A 402 62 HETNAM ZN ZINC ION HETNAM L5C N-[4-[[3-[2-(4,6-DIMETHYLPYRIMIDIN-2-YL) HETNAM 2 L5C SULFANYLETHANOYLAMINO]PHENYL]METHOXY]PHENYL]-1-METHYL- HETNAM 3 L5C PYRAZOLE-4-CARBOXAMIDE FORMUL 2 ZN ZN 2+ FORMUL 3 L5C C26 H26 N6 O3 S FORMUL 4 HOH *353(H2 O) HELIX 1 AA1 THR A 63 GLN A 72 1 10 HELIX 2 AA2 ALA A 85 GLY A 92 5 8 HELIX 3 AA3 TYR A 114 PHE A 119 5 6 HELIX 4 AA4 GLU A 120 HIS A 127 1 8 HELIX 5 AA5 PRO A 128 TYR A 139 1 12 HELIX 6 AA6 THR A 146 LYS A 158 1 13 HELIX 7 AA7 THR A 171 ALA A 176 1 6 HELIX 8 AA8 GLU A 179 GLU A 181 5 3 HELIX 9 AA9 LEU A 206 GLU A 216 1 11 HELIX 10 AB1 PRO A 240 PHE A 251 1 12 HELIX 11 AB2 PRO A 268 ALA A 276 5 9 HELIX 12 AB3 GLU A 323 LEU A 335 1 13 HELIX 13 AB4 TRP A 337 ALA A 354 1 18 SHEET 1 AA1 6 LEU A 183 GLU A 185 0 SHEET 2 AA1 6 LEU A 161 THR A 166 1 N THR A 166 O VAL A 184 SHEET 3 AA1 6 VAL A 79 VAL A 83 1 N CYS A 81 O TYR A 165 SHEET 4 AA1 6 LEU A 256 MET A 260 1 O LEU A 258 N ILE A 80 SHEET 5 AA1 6 ARG A 282 ASN A 286 1 O LEU A 283 N VAL A 259 SHEET 6 AA1 6 ASP A 317 LEU A 321 1 O VAL A 318 N LEU A 284 SHEET 1 AA2 3 GLU A 203 PRO A 205 0 SHEET 2 AA2 3 GLY A 188 CYS A 195 -1 N SER A 193 O TYR A 204 SHEET 3 AA2 3 VAL A 228 ILE A 232 -1 O ASP A 231 N THR A 192 LINK SG CYS A 195 ZN ZN A 401 1555 1555 2.35 LINK SG CYS A 200 ZN ZN A 401 1555 1555 2.30 LINK SG CYS A 221 ZN ZN A 401 1555 1555 2.33 LINK SG CYS A 224 ZN ZN A 401 1555 1555 2.29 CISPEP 1 GLN A 267 PRO A 268 0 4.36 SITE 1 AC1 4 CYS A 195 CYS A 200 CYS A 221 CYS A 224 SITE 1 AC2 16 PHE A 96 ARG A 97 PHE A 119 PHE A 131 SITE 2 AC2 16 ALA A 135 LEU A 138 TYR A 139 PRO A 140 SITE 3 AC2 16 PHE A 143 ILE A 169 HIS A 187 PHE A 190 SITE 4 AC2 16 LEU A 206 VAL A 233 PHE A 235 GLN A 267 CRYST1 35.938 73.918 55.635 90.00 95.24 90.00 P 1 21 1 2 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.027826 0.000000 0.002553 0.00000 SCALE2 0.000000 0.013529 0.000000 0.00000 SCALE3 0.000000 0.000000 0.018050 0.00000